We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+3.66%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$38.5B
AUM Growth
-$94.6M
Cap. Flow
-$610M
Cap. Flow %
-1.59%
Top 10 Hldgs %
32.15%
Holding
905
New
35
Increased
311
Reduced
451
Closed
48

Top Buys

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$87M
2
AAPL icon
Apple
AAPL
+$77.5M
3
TJX icon
TJX Companies
TJX
+$77.2M
4
APO icon
Apollo Global Management
APO
+$38.2M
5
ETN icon
Eaton
ETN
+$36.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$82.1M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$51M
3
GEV icon
GE Vernova
GEV
+$46.5M
4
DAL icon
Delta Air Lines
DAL
+$41.8M
5
MA icon
Mastercard
MA
+$38.6M

Sector Composition

Rank Sector Weight
1 Technology 32.09%
2 Financials 14.17%
3 Consumer Discretionary 11.21%
4 Healthcare 10%
5 Communication Services 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FN icon
726
Fabrinet
FN
$14.9B
$571K ﹤0.01%
2,599
-203
-7% -$48.9K
AOS icon
727
A.O. Smith
AOS
$8.55B
$571K ﹤0.01%
8,365
+441
+6% +$33.4K
BLBD icon
728
Blue Bird Corp
BLBD
$2.29B
$570K ﹤0.01%
14,768
+1,740
+13% +$72.7K
IOSP icon
729
Innospec
IOSP
$2.09B
$570K ﹤0.01%
5,181
-648
-11% -$74.2K
MLI icon
730
Mueller Industries
MLI
$14.5B
$570K ﹤0.01%
14,368
-4,120
-22% -$167K
PLAB icon
731
Photronics
PLAB
$1.65B
$570K ﹤0.01%
24,196
-3,662
-13% -$89.6K
KTB icon
732
Kontoor Brands
KTB
$4.71B
$569K ﹤0.01%
6,657
-2,008
-23% -$172K
ACLS icon
733
Axcelis
ACLS
$3.44B
$568K ﹤0.01%
8,132
+1,877
+30% +$156K
RMBS icon
734
Rambus
RMBS
$8.98B
$568K ﹤0.01%
10,748
-5,156
-32% -$263K
AGX icon
735
Argan
AGX
$6.9B
$567K ﹤0.01%
4,141
-3,186
-43% -$438K
LSTR icon
736
Landstar System
LSTR
$6.04B
$567K ﹤0.01%
3,301
-218
-6% -$39.9K
CELH icon
737
Celsius Holdings
CELH
$7.38B
$567K ﹤0.01%
21,530
+3,187
+17% +$94.5K
EXPO icon
738
Exponent
EXPO
$3.19B
$567K ﹤0.01%
6,359
+336
+6% +$33.8K
DINO icon
739
HF Sinclair
DINO
$16.2B
$567K ﹤0.01%
+16,164
New +$661K
USNA icon
740
Usana Health Sciences
USNA
$419M
$566K ﹤0.01%
15,777
-1,040
-6% -$38.9K
SIGA icon
741
SIGA Technologies
SIGA
$240M
$566K ﹤0.01%
94,165
+18,887
+25% +$126K
HEI.A icon
742
HEICO Corp Class A
HEI.A
$36B
$566K ﹤0.01%
3,041
-7
-0.2% -$1.41K
MZTI
743
The Marzetti Company
MZTI
$3.05B
$565K ﹤0.01%
3,264
-409
-11% -$74.9K
PTGX icon
744
Protagonist Therapeutics
PTGX
$8.55B
$565K ﹤0.01%
+14,627
New +$638K
SUI icon
745
Sun Communities
SUI
$15.8B
$564K ﹤0.01%
4,589
-100
-2% -$12.8K
EVR icon
746
Evercore
EVR
$11.8B
$563K ﹤0.01%
2,030
+261
+15% +$73.9K
PLUS icon
747
ePlus
PLUS
$2.43B
$562K ﹤0.01%
7,605
+735
+11% +$64.2K
LMAT icon
748
LeMaitre Vascular
LMAT
$2.37B
$562K ﹤0.01%
6,097
-1,105
-15% -$106K
CRVL icon
749
CorVel
CRVL
$3.18B
$562K ﹤0.01%
5,049
-1,185
-19% -$133K
CNS icon
750
Cohen & Steers
CNS
$4.2B
$559K ﹤0.01%
6,059
-1,087
-15% -$108K

Similar funds

Aviva's Q4 2024 Portfolio in Review

As of Q4 2024, Aviva held 905 positions worth $38.5B, down 0.24% from $38.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Aviva's Q4 2024 filing shows 35 new, 311 increased, 451 reduced and 48 closed positions. Its largest new stake was EQT Corp: 319,206 shares worth $14.7M. The largest sale was UnitedHealth, an estimated $82.1M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Aviva's largest Q4 2024 buy was EQT Corp: 319,206 shares worth $14.7M.
  • Aviva added most to Spotify in Q4 2024, an estimated $87M increase.
  • Aviva's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $82.1M.
  • Aviva fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $37.4M.
  • Aviva's ten largest holdings make up 32% of its $38.5B portfolio in Q4 2024.
  • Aviva opened 35 new positions and closed 48 in Q4 2024.
  • Aviva's portfolio value fell 0.24% quarter-over-quarter to $38.5B.

Based on Aviva's 13F filing for Q4 2024, filed 13 Feb 2025.